1. TFOS Ambassadors

Ecuador

Karla Arteaga

Karla Arteaga Rivera MD, 
 
Medical Degree from Estatal University of Guayaquil  
Ophthalmologist from Superior School of Ophthalmology – Barraquer Institute of America in Bogotá – Colombia. 
Cornea, Refractive Surgery and External Diseases fellowship in CONDE de Valenciana Institute/ UNAM, Mexico City – Mexico.
I do my private practice at  Centro de Diagnostico Ocular in Guayaquil and I am head of the Ophthalmology department at Hospital Luis Vernaza, the largest hospital of the region. 
Current vice-president of the National Society of Ophthalmology of Guayas 
Publications:
  • Prevalence of hyperthyroidism, hypothyroidism and euthyroidism in thyroid eye disease: A systematic review of the literature. Systematic Reviews. 2020. 
  • A white circular – spot pattern of iridian atrophy associated with Varicella – zoster virus and toxoplasma gondii coinfection: a case report. BMC Ophthalmology. 2020. 
  • Severe sequeale of bilateral chronic non – granulomatous anterior uveitis secondary to the use of oral moxifloxacin: Case report. Journal of Medical Case Reports. 2021. 
  • Consultation article. Journal of Cataract and Refractive Surgery Section. December 2020 
  • Results of Lucia Keratoprosthesis Implantation in Severe Corneal Disease. AAO December 2024.
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members